Register by March 21 and SAVE!
Participating Organizations:
AstraZeneca R&D
Basilea Pharmaceuticals
Case Western Reserve University School of Medicine
Inimex Pharmaceuticals
Merck Research Laboratory
Replidyne Inc.
Targanta Pharmaceuticals
The Scripps Research Institute
Wyeth
and more . . .
Sessions Include:
Defense Strategies
Natural Product – Based Screening
Approaches by Structure, Bioinformatics and Models
Funding and Collaboration Strategies
Beta-Lactam Antibiotics
Identifying Novel Targets
The Challenge of Selecting Novel Therapeutics